FOR SUPPORT, CALL 1-866-APF-3635 (273-3635)

 
  For Patients
  For Healthcare Professionals
  Safe / Unsafe Drug Database
  Emergency Room Guidelines

Disc Medicine Submits a New Drug Application to the FDA for Acceleratent Approval of Bitopertin for EPP

  • Monday, October 6, 2025

Disc Medicine Submits a New Drug Application to the FDA for Acceleratent Approval of Bitopertin for EPP. Read the news here.

Disc Medicine Submits a New Drug Application to the FDA for Acceleratent Approval of Bitopertin for EPP